Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Bitcoin Has Fallen 50% From Its Peak. History Points to What Comes Next.fool.com
Bitcoin is down 50% from its October 2025 peak. Here's what previous cycles say about the road ahead.
Via The Motley Fool · July 14, 2026
Here's Why Newmont Stock Popped Today (Hint: Wall Street Likes its Valuation)fool.com
Long-term gold bulls need to be patient as there's probably still a lot of speculative money in the trade.
Via The Motley Fool · July 14, 2026
DLocal Director Sebastian Kanovich Sells 25,700 Shares for $398,350 -- Is the Stock a Sell Too?fool.com
Kanovich liquidated his entire direct Class A position under a pre-arranged trading plan, though he retains 11.6 million convertible Class B shares.
Via The Motley Fool · July 14, 2026
Why NioCorp Stock Soared Todayfool.com
The NioCorp CEO just gave investors great news.
Via The Motley Fool · July 14, 2026
Had You Bought This Magnificent Vanguard ETF at the Start of January, You'd Be Crushing the S&P 500 in 2026fool.com
Technology stocks are driving the broader market higher yet again in 2026.
Via The Motley Fool · July 14, 2026
Fed Chair Kevin Warsh Just Got Great Newsfool.com
Inflation slowed in June.
Via The Motley Fool · July 14, 2026
No Space For Panic: T-Mobile Shrugs Off The Starlink Threatmarketbeat.com
Amid satellite-disruption fears hitting telecoms, T-Mobile's spectrum swaps, SpaceX partnership, and enterprise push support analyst upgrades and a premium valuation versus AT&T and Verizon.
Via MarketBeat · July 14, 2026
SpaceX Is Declining: Could This Unstoppable ETF Be the Best Way to Invest in It This Year?fool.com
Others are likely to perform better, but it may be a good addition to your portfolio.
Via The Motley Fool · July 14, 2026
Buying TSMC Stock Before July 16 Just Became a No-Brainer Due to This Massive Newsfool.com
TSMC's June revenue report suggests that the stock is poised for bigger gains in the second half of 2026.
Via The Motley Fool · July 14, 2026
3 Reasons Nvidia Stock Could Keep Soaring Through 2026fool.com
The stock is poised to push beyond its $5.1 trillion market value.
Via The Motley Fool · July 14, 2026
Why Micron Technology Stock Rallied on Tuesdayfool.com
The chipmaker got a vote of confidence from Wall Street.
Via The Motley Fool · July 14, 2026
The Goldman Sachs Group Q2 Earnings Call Highlightsmarketbeat.com
The Goldman Sachs Group (NYSE:GS) reported record second-quarter 2026 results, with Chairman and Chief Executive Officer David Solomon citing strong client activity, an acceleration in strategic dealmaking and rising demand tied to artificial intelligence infrastructure investment. Goldman generate
Via MarketBeat · July 14, 2026
FB Financial Q2 Earnings Call Highlightsmarketbeat.com
FB Financial (NYSE:FBK) reported higher second-quarter 2026 earnings and balance sheet growth, with management pointing to broad-based loan demand across its Southeast footprint while acknowledging continued pressure from competition for deposits and lending relationships. President and Chief Execu
Via MarketBeat · July 14, 2026
Mark Cuban Says He’d Still Sell Dallas Mavericks for All the Reasons He’s Said ‘100 Times’ — But Would ‘Absolutely Not’ Do It the Same Way Againbenzinga.com
Selling a business is a little like selling a house. Even when the price is right, it’s easy to replay the "what ifs" long after the papers are signed. Billionaire entrepreneur and former Dallas Mavericks
Via Benzinga · July 14, 2026
Stock of the Day: AppLovin Bounces Off Support — But Where's the Floor?benzinga.com
AppLovin Corp (APP) stock bounces back after sell-off, supported at $442 level. Investor psychology creates & maintains support levels at $442 and $372.50.
Via Benzinga · July 14, 2026
Logement à louer Trois-Rivières : comment trouver la location idéale pour votre séjourtalkmarkets.com
Pourquoi choisir Trois-Rivières pour votre prochain logement ?Située entre Montréal et Québec, Trois-Rivières est une ville dynamique qui séduit autant les
Via Talk Markets · July 14, 2026
Johnson & Johnson Q2 Preview: Stock Near All-Time Highs, Market Expert Sees Rally to $282 – ‘Continue Their Winning Ways’benzinga.com
Johnson & Johnson stock trades near all-time highs. A strong Q2 report and the chart show more upside ahead.
Via Benzinga · July 14, 2026
Nebius Stock Jumps on $1 Billion AI Infrastructure Dealbenzinga.com
Nebius shares gained after securing a multi-year AI infrastructure agreement worth over $1 billion with startup Reflection AI through 2029.
Via Benzinga · July 14, 2026
TSMC's 68% Sales Surge Just Validated This Billionaire's $9.5 Billion Betbenzinga.com
TSMC reported 67.9% June sales growth ahead of earnings, reinforcing billionaire Lewis Sanders' $9.5 billion investment in the AI chip giant.
Via Benzinga · July 14, 2026
Why Is Sandisk Stock Surging on Tuesday?benzinga.com
Sandisk Corp. (NASDAQ:SNDK) stock surged 5% on Tuesday. Read how Goldman Sachs momentum data and Bank of America’s $2,500 price target drive the rebound.
Via Benzinga · July 14, 2026
After SpaceX, XOVR ETF Bets $30 Million on Kalshi as Prediction Markets Heat Upbenzinga.com
ERShares' XOVR ETF makes Kalshi one of its largest private holdings after SpaceX, reinforcing its strategy of investing before companies go public.
Via Benzinga · July 14, 2026
What's Going On with Oracle on Tuesday?benzinga.com
Oracle shares slip as IBM's disappointing preliminary earnings pressure enterprise software stocks despite Oracle unveiling new AI capabilities.
Via Benzinga · July 14, 2026
New Education Policy 2020: Transforming the Future of Education in Indiatalkmarkets.com
The New Education Policy (NEP) 2020 is one of the most significant reforms in India's education system. Approved by the Government of India on 29 July 2020
Via Talk Markets · July 14, 2026
Hynix Isn't Selling Shares to Cash Out. It's Funding a $26.5 Billion Factory Bet.fool.com
The opportunity behind these recently raised funds is nothing less than amazing.
Via The Motley Fool · July 14, 2026
Why Is Biogen Stock Falling Tuesday?benzinga.com
Biogen stock drops 9% as Phase 2 diranersen data raises analyst questions, despite Phase 3 plans and a new weekly LEQEMBI FDA approval.
Via Benzinga · July 14, 2026